Institution: “Grigore T. Popa” University of Medicine and Pharmacy
Location: Iași, Romania
Prof. Covic is a Professor of Nephrology and Internal Medicine at the “Grigore T. Popa” University of Medicine and Pharmacy, the Director of the Nephrology Clinic and the Dialysis and Transplantation Center in Iasi, Romania. In the past he served as President of the Romanian Society of Nephrology and Secretary Treasurer of ERA-EDTA.
Prof. Covic started his clinical and research activity as a fellow in Nephrology in Manchester and Amiens. Later he performed clinical research at the Case Western University in Cleveland, Ohio. He received a Ph.D. on: “Cardiovascular abnormalities and its determinant factors in chronic renal failure” in 1997. Since 2007, he is a FRCP (London) and became in 2009 a member of the Romanian Academy of Medical Sciences. From 2011 he is also a Fellow of the ERA EDTA (FERA).
Prof. Covic published more than 410 original and review papers in peer-reviewed journals, 14 books and 22 chapters. The current Hirsch Index is 48.
He is an Associate Editor for NDT, and Editor in Chief (Nephrology) for the International Journal of Urology and Nephrology, and editor / reviewer for several prestigious journals.
His main areas of interest are: cardiovascular complications in renal disease, CKD-MBD, renal anaemia, peritoneal dialysis, and acute renal failure.
Prof. Covic is the Vice-Rector (Research) of the University of Medicine “Gr. T. POPA” Iasi, Romania and a board member of KDIGO, ERBP, and ERA-EDTA working groups – EURECAM and CKD-MBD.
Prof Covic has organized several regional European educational courses under the auspices of ERA EDTA and ISN. For a mandate he has been chair of the ISN/COMGAN Eastern Europe.
An De Vriese
Institution: AZ Sint-Jan
Location: Brugge, Belgium
An De Vriese is head of the Department of Internal Medicine and of the Division of Nephrology and Infectious Disease in AZ Sint-Jan Brugge.
She is author of over 140 publications in peer-reviewed medical journals. Her interest is focussed on clinical studies in hemodialysis and peritoneal dialysis.
An De Vriese received her degree in Medicine summa cum laude from the Ghent University in 1992. She also studied at the University of the Free State, Bloemfontein, RSA and performed research at the Institute for Anatomy and Cell Biology, Ruprecht-Karls-University, Heidelberg, and at the Institute de Recherches Servier, Paris. She was Research Assistant of the Belgian National Fund for Scientific Research and obtained a Ph.D. in Medical Science in 2001.
Institution: University Hospital Zurich
Location: Zurich, Switzerland
Olivier Devuyst, MD, PhD, is Full Professor in Medicine and Physiology at the University of Zurich (Switzerland) and has joint appointments in the Division of Nephrology of the Saint-Luc Academic Hospital, UCL Medical School (Brussels).
Dr. Devuyst and his group investigate the molecular mechanisms of the transport of water and solutes across epithelia, and the pathophysiology of inherited renal tubular diseases and their progression. These studies, which have generated more than 300 peer-reviewed articles, are funded by national and international agencies, including the European Union and the NIH. Dr. Devuyst has been the laureate of several international prizes and has been elected at the Royal Academy of Medicine of Belgium in 2005. He is Associate Editor of Nephrology Dialysis Transplantation, Peritoneal Dialysis International, and Orphanet Journal of Rare Diseases, and he serves in the Editorial Board of Clin J Am Soc Nephrol, Kidney International and Pflügers Archiv.
Institution: University Claude Bernard Lyon 1 and Centre Hospitalier Lyon Sud
Location: Lyon, France
Denis Fouque, MD, PhD, is Professor of Nephrology at the University Claude Bernard Lyon1, and Associate Chief of the Division of Nephrology at the Centre Hospitalier Lyon Sud in Lyon, France. He is the past Research Vice President (Health Affairs) at the Université Claude Bernard Lyon, the largest medical school in France (2012-2016). Dr Fouque has published 280 papers, including reviews, meta-analyses and 18 book chapters, among which 2 chapters in The Kidney, Brenner and Rector, 2012 and 2015. His current h factor is 52. His research fields are in nutrition and metabolism in chronic kidney disease and dialysis. He is director of the adipocyte dysfunction research group in INSERM 1060 at the University Claude Bernard Lyon1. Dr Fouque also got training in Evidence based Medicine by founding the Cochrane Collaboration Renal Group in 1997 and being the Co-ordinating Editor until 2001. Dr Fouque was President of the International Society for Renal Nutrition and Metabolism (2004–2006), Editor-in-Chief of the Journal of Renal Nutrition (2003-2011) and chairman of the ERA-EDTA Nutrition Guideline (2007). Dr Fouque is currently vice-chairman of the European Renal Best Practice group of ERA-EDTA. He has been an ERA-EDTA Council member from 2012 to 2015, and is the Editor-in-chief elect of Nephrology Dialysis Transplantation.
Hiddo Lambers Heerspink
Institution: University Medical Center Groningen
Location: Groningen, Netherlands
Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands. He received his PhD degree from the medical faculty of the University Medical Center Groningen in 2008. He then worked as a post-doctoral fellow at The George Institute in Sydney, Australia where he investigated the effects of blood pressure lowering regimens on renal and cardiovascular outcomes in patients with renal impairment. Based on this work, he was awarded a young investigator grant and subsequently in 2015 a consolidator investigator grant from the Dutch organisation of scientific research.
Since 2010, Doctor Lambers Heerspink has held a position as a Clinical Pharmacologist at the University Medical Center Groningen. He is currently Professor Clinical Trials and Personalized Medicine. His main research interests include optimising treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular disease. His particular clinical research interest is to identify determinants of individual treatment responses and ways to optimize drug response in individual patients. To achieve these goals he is involved in various international clinical trials and uses biomarkers and imaging techniques to unravel pathways and determinants of therapy response.
Institution: Hôpital Necker
Location: Paris, France
Christophe Legendre, MD, is professor of Nephrology at Paris Descartes University and Head of the Adult Nephrology and Transplantation Unit at Necker Hospital in Paris.
Hospital titles :
- Resident, Montpellier, France,1980,
- Senior resident in Montpellier then in Paris, Hôp. Necker, France, 1986-1990
- Praticien hospitalier, Hôp Necker, AP-HP, Paris, France, 1991
- Head of Nephrology Unit, Hôp. Saint-Louis, Paris, France 1997-2004
- Head of Transplant Unit, Hôp. Necker, Paris, France 2004-12
- Head of Nephrology-Transplant Unit, Hôp Necker, Paris, France, 2012-
- Head of IRISE « pôle », Hop Necker, Paris, France, 2012-
- Academic titles:
- Doctor in Medicine, Montpellier, France, 1986
- Master’s of Sciences, Université Mc Gill, Montréal, Canada, 1986
- Chef de clinique in Montpellier then in Paris, Hôp. Necker, France, 1986-1990
- Diploma of Habilitation to conduct research, Paris, France, 1992
- Professor of Nephrology (C2-92, C1-02, CEx1-12, CEx2-16), Paris Descartes, France
- Research experience : post-doctoral fellowship in the Immunogenetics and Histocompatibility laboratory (Pr RD Guttmann), Royal Victoria Hospital, Mc Gill university, Montréal, Canada 1983-1986, Young Investigator Award of American Society of Transplant Physicians, Chicago, USA,1986
- Editorial board : Transplantation, NDT, Transplant International, Transplantation Reviews, Trends in Transplantation, Frontiers in Alloimmunity and Transplantation
- Associate Editor : Am J Transplant (07-14), Deputy Editor:Transplantation (13-), Associate Editor Kidney Int (2014-)
- Publications : 431 international papers, H-index = 73
- Specificities : important clinical practice in the field of renal transplantation at Saint-Louis hospital and then at Necker (#200 RT/y, 9 000 clinics/y). Main interests in clinical research in the following fields : viruses in transplantation (B et C hepatitis, CMV, HHV6,7,8), evaluation of various immunosuppressive drugs (OKT3, anti-TCR, sirolimus, FTY720, belatacept, eculizumab, tofacitinib), routine biopsies, aHUS, patients with DSAs, chronic humoral rejection. Experience as PI in clinical trials in transplantation since 1987. Member of the Board of Directors of the Agence de la Biomédecine (2005- 8), Société de Néphrologie (07-13), ESOT Educational Comittee (Hesperis course 09-13), SFT (2015-)
- Reviewer : AJT, Transplantation, NDT, Transplant International, Trends in Transplantation, Transplantation Reviews, Frontiers in Alloimmunity and Transplantation
- Societies :SN, SFT, ESOT, EDTA, AST, ASN, TTS.
- Member of the Conseil National des Universités ( CNU, 2003-09).
- Unité INSERM U 1151, Hôpital Necker
Institution: King’s College Hospital
Location: London, UK
Professor Iain Macdougall is Professor of Clinical Nephrology at King’s College Hospital having originally been appointed as a Consultant Nephrologist there in 1996. His early training was at the University of Glasgow from where he gained a First class Honours BSc degree in Pharmacology (1980), followed by his medical degree in 1983. Early postgraduate medical training was in various hospitals in Glasgow, before moving to Cardiff as a Clinical Research Fellow in 1988 where he developed his research interest in renal anaemia. He completed his renal training at St Bartholomew’s Hospital in London, and continued to have a strong sub-specialty interest in the anaemia associated with chronic kidney disease, for which he is now internationally renowned. He has been on the steering committee or the UK lead of several pivotal clinical trials which have shaped the management of renal anaemia worldwide, including CREATE, TREAT, and FIND-CKD, and he chairs the Anaemia Clinical Study Group of the UK Kidney Research Consortium.
He has been involved in numerous advisory boards in renal anaemia management worldwide, including the Working Parties responsible for both the 1999 and the 2004 versions of the European Best Practice Guidelines, as well as the Work Groups that produced both the 2006 US KDOQI and the 2012 KDIGO Guidelines on Renal Anaemia Management, He is frequently invited to lecture internationally, and has published 22 book chapters and over 200 scientific papers, mainly in the field of renal anaemia. In 2016, he receive a National Institute for Health Research award for excellence in research leadership in the UK.
Institution: University College Dublin
Location: Dublin, Ireland
Patrick Murray is Professor of Clinical Pharmacology in University College Dublin, and a consultant physician (clinical pharmacologist & nephrologist) at the Mater Misericordiae University Hospital, Dublin, Ireland.
He received his medical education at University College Dublin, Ireland.
Following his internship at the Mater Misericordiae University Hospital in Dublin, he completed a residency in internal medicine at Hennepin County Medical Center in Minneapolis, Minnesota, USA.
He completed fellowship training programs in nephrology, critical care medicine, and clinical pharmacology at the University Of Chicago Hospitals in Chicago, Illinois, USA.
He is board-certified in nephrology, critical care medicine, and clinical pharmacology.
He practiced as an intensivist, nephrologist, and clinical pharmacologist at the University of Chicago Hospitals from 1996–2008, serving as the fellowship training program director in nephrology, also directing the Acute Dialysis Service.
He has a longstanding interest in research and education to improve the prevention, diagnosis, and therapy of acute kidney injury and nephrotoxicity, and the pharmacotherapy of patients with kidney disease. He is a member of several international consensus groups that have produced guidelines for research and practice in the field of acute kidney injury (ADQI, AKIN, KDOQI).
Since 2008, he has been the Professor of Clinical Pharmacology at University College Dublin, and a Consultant in Nephrology & Clinical Pharmacology at the Mater Misericordiae University Hospital. He is Chair of the Mater Misericordiae University Hospital Drugs & Therapeutics Committee. He is the Clinical Director of the UCD-Mater Clinical Research Centre. In 2011, he was appointed Associate Dean for International Affairs in the UCD School of Medicine and Medical Science. In 2012, he was appointed Director of the Dublin Centre for Clinical Research (DCCR) Consortium Network, and also Clinical Director of the Irish Clinical Research Infrastructure Network (ICRIN). Since December 2012, he has been the Dean and Head of the School of Medicine at UCD.
Institution: Medical University of Vienna
Location: Vienna, Austria
Rainer Oberbauer is Professor of Medicine and Director of the Department of Nephrology & Dialysis and Transplant Medicine at the Medical University of Vienna, Vienna, AUSTRIA
Dr. Oberbauer received his MD from the University of Vienna, Austria in 1990 and his MSc in Epidemiology from the Harvard School of Public Health, USA in 2005. He completed his fellowship in nephrology at the Universities of Vienna and Stanford, became Assistant Professor of Medicine in Vienna in 1996 and advanced to Associate Professor in 1999. In 2006 he was promoted to Director of the Renal Department of the Elisabethinen Hospital, Linz, Austria and 2014 to Director of the Department for Nephrology and Dialysis, Internal Medicine III, Medical University of Vienna.
Dr. Oberbauer has a longstanding clinical and scientific interest in renal transplantation and he has published numerous experimental as well as clinical papers in this field. He is a member of many international transplant societies, current chair of EKITA and is EIC of Transplant Int and on the editorial board of a number of other major international transplant journals. He has also received several academic awards for his scientific papers, which mainly focus on genetic and clinical epidemiology and new immunosuppressive strategies following renal transplantation.
Institution: Imperial College London
Location: London, UK
Charles D Pusey DSc FRCP FRCPath FMedSci FRSB is Professor of Medicine and Head of the Renal and Vascular Inflammation Section in the Department of Medicine at Imperial College London, and Honorary Consultant Physician in the Directorate of Renal Medicine and Transplantation at Imperial College Healthcare NHS Trust. He qualified in Medicine from Cambridge University and Guy’s Hospital, London, and trained in Renal Medicine in the Royal Air Force and at the Royal Postgraduate Medical School, Hammersmith Hospital. His research is focused on autoimmunity and inflammation in renal disease, including the mechanisms underlying primary and secondary glomerulonephritis, and he has a particular clinical interest in systemic vasculitis.
Institution: Radboud University Nijmegen
Location: Nijmegen, Netherlands
Jack Wetzels is a Professor of Nephrology at Radboud University Nijmegen.
Jack F M Wetzels (1954) was born in Heerlen, The Netherlands. He studied Medicine at the Radboud University Nijmegen, and received his MD in 1980. He was trained in Internal Medicine and Nephrology at the Radboud University Nijmegen Medical center. He received his Ph.D. in 1989. From 1990 to 1992 he worked as a postdoctoral fellow under supervision of Robert W Schrier at the University of Colorado Health Sciences Center in Denver, CO, USA. Since 1992 he is working as academic nephrologist. In 2002 he was appointed Professor of Nephrology at the Department of Nephrology at Radboud University Nijmegen. His chair is committed to teaching and research with an emphasis on the diagnosis and treatment of patients with glomerular diseases.
Institution: Riuniti Hospital
Location: Reggio Calabria, Italy
Prof. Zoccali is a clinical Investigator and Research Unit head of the Clinical Epidemiology of Renal Diseases and Hypertension Unit of the National Research Council (Consiglio Nazionale delle Ricerche, CNR) – IFC at Riuniti Hospital, Reggio Calabria.
Prof. Zoccali’s research interests cover hypertension, cardiovascular complications in chronic renal failure, renal disease progression and the epidemiology of chronic renal failure. He has contributed over 600 PudMed indexed publications in peer reviewed journals and has an Hirsh Index (Google Scholar) of 80. Prof. Zoccali is Chief Editor of Nephrology, Dialysis and Transplantation and editorial board member of JASN, cJASN, Hypertension, European J Clin Investigation, Clinical Nephrology and several other internal medicine and nephrology journals.
Prof. Zoccali is the President Elect of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) for the 2017-2020 triennium. He chaired the Registry of Dialysis and Transplantation of the same association from 2003 until May 2009. A member to 10 national and international societies of Nephrology and Hypertension, he received international awards by the Am Kidney Foundation and the Borelli Foundation. Prof. Zoccali is Fellow of the American Society of Nephrology